Негенетические факторы риска и протективные факторы при психических расстройствах: атлас, основанный на доказательных исследованиях

1 Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Madrid, Spain; 2 Health Research Institute (IiGSM), School of Medicine, Universidad Complutense de Madrid, Madrid, Spain; 3 Biomedical Research Center for Mental Health (CIBERSAM), Madrid, Spain; 4 Pain and Rehabilitation Centre and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 5 Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK; 6 Department of Neuroscience, University of Padua, Padua, Italy; 7 Department of Psychiatry, University of Ottawa and Department of Mental Health, Ottawa Hospital, Ottawa, ON, Canada; 8 Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK; 9 Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK; 10Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK; 11Hassenfeld Children’s Hospital at NYU Langone, New York, NY, USA; 12Department of Psychiatry and Psychotherapy, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany; 13Centerfor Basicsin NeuroModulation, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 14Department of Psychosis Studies, King’s College London, London, UK; 15Department of Psychiatry, University of Cambridge, Cambridge, UK; 16CAMEO Early Intervention Service, Cambridgeshire and Peterborough National Health Service Foundation Trust, Cambridge, UK; 17Department of Psychiatry, Dalhousie University, Halifax, NS, Canada; 18Nova Scotia Health, Halifax, NS, Canada; 19IWK Health Centre, Halifax, NS, Canada; 20Department of Medical Neuroscience, Dalhousie University, Halifax, NS, Canada; 21IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia; 22Department of Psychiatry, University of Toronto, and Centre for Addiction and Mental Health, Toronto, ON, Canada; 23Department of Psychiatry, Icahn School of Medicine at Mount Sinai, NewYork, NY, USA; 24Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 25Seaver Center for Autism Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 26Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea; 27Department of Pediatrics, Severance Children’s Hospital, Seoul, South Korea; 28NORMENT – Institute of Clinical Medicine, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway; 29Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; 30Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; 31Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA; 32Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; 33OASIS Service, South London and Maudsley NHS Foundation Trust, London, UK; 34Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy